-
DE30 loses more than 1.5% and tests the barrier at 15,800 points
-
Company results: Fraport (FRA.DE), Bayer (BAYN.DE)
-
NovoNordisk (NOVOB.DK) shares at historic highs after new study of drug Wegova
Tuesday's session on European markets brings clear declines in the quotations of European benchmarks. The reason for such large sell-offs today is mainly due to the reaction to weak trade data from China and the wave of panic in Italy, where banks there are recording sizable declines after the decision to introduce a 40% tax on extraordinary profits.
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appThe mood in Europe weakened markedly during Tuesday's trading session. Sectors trying to resist the downward pressure are now pharmaceuticals (excluding Bayer (BAYN.DE)). Source: xStation 5
Futures based on the German DE30 are breaking out to the downside towards the 15,800-point barrier, thus recording close to 1.5% declines on a daily basis. Source: xStation 5
News
Fraport (FRA.DE) shares are gaining nearly 6% today following the publication of better-than-expected quarterly results. For the first half of the year, EBITDA came in at €481.4 million against expectations of €475.7 million, revenues were €1.8 billion against expectations of €1.67 billion. For Q2 alone, the company's revenue was €1.04 billion against the expected €918.3 million.
Passenger numbers at Frankfurt this year are expected to reach the mid-range of the previously stated forecast of at least 80% to 90% of the traffic recorded in 2019. In terms of earnings forecasts, the company's EBITDA is expected to reach the upper end of the previously forecast range of €1.04 billion to €1.2 billion.
Source: xStation 5
Market sentiment is much weaker on Bayer (BAYN.DE) shares. The company has lowered its revenue forecasts for the Crop and Pharmaceuticals unit (given the result warnings issued last month). Crop unit revenue levels are expected to fall by 5% this year due to weaker momentum in glyphostat sales (previously forecast to rise by 3%).
As reported by analysts Morgan Stanley and UBS, today's declines are largely dictated by the lack of consensus adjustment following the earnings warning issued a month ago.
Details of the company's earnings report. Source: Bloomberg Finance L.P.
Major percentage changes in individual companies of the DAX index. Source: Bloomberg Finance L.P.
Information from individual companies in the DAX index. Source: Bloomberg Finance L.P.
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
